BioSpace News Archive

Albany NY, United States: The rise in beauty standards worldwide is likely to add as a notable factor boosting the global liposuction surgery devices market during the forecast period, 2020 to 2030.

Calibre Scientific is pleased to announce the acquisition of Serviquimia, a high-quality distributor of consumables, chemicals, lab equipment, and lab furniture, headquartered in Tarragona, Spain.

We have completed the manufacturing of GP2, released 3 clinical lots, and started the stability testing program for these lots.

Exavir Therapeutics, a company dedicated to transforming the lives of people living with or at risk of acquiring HIV, today announced that the company has closed on a $4M seed financing led by AlleyCorp with participation from Gilead Sciences.

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today presented positive data from the largest randomised, controlled, double-blind study of psilocybin therapy ever completed, at the American Psychiatric Association.

Pfizer Inc. and BioNTech SE announced topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age.

First patients dosed in study sub-part evaluating BND-22 in combination with pembrolizumab or with cetuximab.

Albany NY, United States: People suffering from diabetes make use of insulin pens to administer insulin in their bodies.

Salubris Biotherapeutics, Inc. today reported new data from Cohort 2 of the ongoing Phase 1 study evaluating JK07, the Company’s lead drug candidate, for the treatment of heart failure with reduced ejection fraction (HFrEF).

Concert Pharmaceuticals, Inc. today announced positive topline results from its recently completed Phase 3 clinical trial, THRIVE-AA1.